We are live on
!
Find out more
TFCM
Taylor Frigon Capital Management Portfolio holdings
AUM
$214M
1-Year Est. Return
47.29%
This Fund
S&P 500
This Quarter
Est. Return
+20.31%
1 Year Est. Return
+47.29%
3 Year Est. Return
+130.72%
5 Year Est. Return
+143.46%
10 Year Est. Return
–
AUM
$199M
AUM Growth
+$19.3M
(+11%)
Cap. Flow
-$7.08M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
24.13%
Holding
90
New
2
Increased
6
Reduced
77
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tower Semiconductor
TSEM
|
+$2.63M |
| 2 |
OneMain Financial
OMF
|
+$1.37M |
| 3 |
BILL Holdings
BILL
|
+$652K |
| 4 |
RGF
The Real Good Food Company, Inc. Class A Common Stock
RGF
|
+$550K |
| 5 |
AudioCodes
AUDC
|
+$293K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EBIX
Ebix Inc
EBIX
|
+$2.65M |
| 2 |
AYX
Alteryx Inc
AYX
|
+$2.64M |
| 3 |
CYBR
CyberArk
CYBR
|
+$1.65M |
| 4 |
QuickLogic
QUIK
|
+$858K |
| 5 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
+$739K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.38% |
| 2 | Healthcare | 17.24% |
| 3 | Consumer Discretionary | 11.19% |
| 4 | Industrials | 11.13% |
| 5 | Financials | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Flowers Foods
FLO
$1.52B
| $1.17M | 0.59% |
51,805
-248
| -0.5% | -$5.35K |
|
77
Healthcare Realty
HR
$6.58B
| $1.13M | 0.56% |
65,329
-274
| -0.4% | -$4.18K |
|
78
McCormick & Company Non-Voting
MKC
$14.2B
| $1.05M | 0.53% |
15,380
-71
| -0.5% | -$4.64K |
|
79
Bristol-Myers Squibb
BMY
$130B
| $1.02M | 0.51% |
19,859
-109
| -0.5% | -$5.72K |
|
80
FMC
FMC
$1.28B
| $782K | 0.39% |
12,398
-48
| -0.4% | -$2.78K |
|
81
Nano X Imaging
NNOX
$71M
| $779K | 0.39% |
122,266
-838
| -0.7% | -$5.23K |
|
82
Vuzix
VUZI
$218M
| $749K | 0.38% |
359,359
+21,650
| +6% | +$59K |
|
|
AKTS
83
DELISTED
Akoustis Technologies Inc
AKTS
| $694K | 0.35% |
832,372
-6,366
| -0.8% | -$4.28K |
|
|
VLD
84
DELISTED
Velo3D, Inc.
VLD
| $436K | 0.22% |
31,329
-191
| -0.6% | -$7.35K |
|
|
AUGX
85
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $259K | 0.13% |
44,300
-40,700
| -48% | -$214K |
|
|
TGAN
86
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $228K | 0.11% |
62,500
| – | – |
|
87
Microbot Medical
MBOT
$117M
| $20.5K | 0.01% |
12,500
| – | – |
|
|
AYX
88
DELISTED
Alteryx Inc
AYX
| – | – |
-70,161
| Closed | -$2.64M |
|
|
VAPO
89
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| – | – |
-292,268
| Closed | -$739K |
|
|
EBIX
90
DELISTED
Ebix Inc
EBIX
| – | – |
-267,957
| Closed | -$2.65M |
|
Similar funds
SIA
IH
TSS
PFA
IAM
CHA
AFC
NCM
Taylor Frigon Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Taylor Frigon Capital Management held 90 positions worth $199M, up 11% from $180M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Taylor Frigon Capital Management withdrew a net $7.08M in Q4 2023, closing 3 positions and reducing 77 holdings. Its most notable exit was Ebix Inc, an estimated $2.65M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Taylor Frigon Capital Management opened a new position in Tower Semiconductor worth $3.08M.
- Taylor Frigon Capital Management's largest Q4 2023 buy was Tower Semiconductor: 101,005 shares worth $3.08M.
- Taylor Frigon Capital Management added most to BILL Holdings in Q4 2023, an estimated $652K increase.
- Taylor Frigon Capital Management's biggest Q4 2023 reduction was CyberArk, cutting an estimated $1.65M.
- Taylor Frigon Capital Management fully exited Ebix Inc in Q4 2023, selling an estimated $2.65M.
- Taylor Frigon Capital Management's ten largest holdings make up 24% of its $199M portfolio in Q4 2023.
- Taylor Frigon Capital Management opened 2 new positions and closed 3 in Q4 2023.
- Taylor Frigon Capital Management's portfolio value rose 11% quarter-over-quarter to $199M.
Based on Taylor Frigon Capital Management's 13F filing for Q4 2023, filed 30 Jan 2024.